These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31892991)
1. A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts. Lin SY; Miao YR; Hu FF; Hu H; Zhang Q; Li Q; Chen Z; Guo AY J Cancer; 2020; 11(1):251-259. PubMed ID: 31892991 [No Abstract] [Full Text] [Related]
2. Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications. Lin SY; Hu FF; Miao YR; Hu H; Lei Q; Zhang Q; Li Q; Wang H; Chen Z; Guo AY Mol Ther Nucleic Acids; 2019 Dec; 18():476-484. PubMed ID: 31670197 [TBL] [Abstract][Full Text] [Related]
3. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia. Deng C; Zeng T; Zhu P; Zhao S; Huang Z; Huang W; Zhang W; Huang X; Fu L J Cancer Res Clin Oncol; 2023 Sep; 149(12):10015-10025. PubMed ID: 37258721 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia. Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742 [TBL] [Abstract][Full Text] [Related]
5. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model. Yang L; Zhang H; Yang X; Lu T; Ma S; Cheng H; Yen K; Cheng T Front Oncol; 2021; 11():659201. PubMed ID: 34123815 [TBL] [Abstract][Full Text] [Related]
7. A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes. Yin X; Huang H; Huang S; Xu A; Fan F; Luo S; Yan H; Chen L; Sun C; Hu Y Front Oncol; 2020; 10():566. PubMed ID: 32373535 [No Abstract] [Full Text] [Related]
8. DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets. Gabellier L; Bret C; Bossis G; Cartron G; Moreaux J Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036275 [TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia. Fu L; Shi J; Hu K; Wang J; Wang W; Ke X Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238 [TBL] [Abstract][Full Text] [Related]
10. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia. Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737 [TBL] [Abstract][Full Text] [Related]
12. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes. Zhang F; Du H; Hu C; Song Y Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia. Huang S; Lu B; Zhu M; Liu M; Sun Z; Pan X; Wei M Expert Rev Hematol; 2022 Jul; 15(7):657-665. PubMed ID: 35713000 [TBL] [Abstract][Full Text] [Related]
14. A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia. Yu Y; Wang H; Yang JJ; Fang S; Wen YN; Jiao YF; Qian K; Le N; Shan RQ; Gao WJ; Hua BL; Li F Front Oncol; 2023; 13():1144403. PubMed ID: 37064135 [TBL] [Abstract][Full Text] [Related]
15. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia. Shi JL; Fu L; Wang WD Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662 [TBL] [Abstract][Full Text] [Related]
16. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia. Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973 [TBL] [Abstract][Full Text] [Related]
17. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients. Zhu R; Tao H; Lin W; Tang L; Hu Y Front Oncol; 2020; 10():574939. PubMed ID: 33330048 [TBL] [Abstract][Full Text] [Related]
18. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia. Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658 [TBL] [Abstract][Full Text] [Related]
19. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia. Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879 [TBL] [Abstract][Full Text] [Related]
20. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia. Huang Y; Zou Y; Lin L; Ma X; Chen H Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]